Selective Binding Of Endostatin Peptide 4 To Recombinant Vegf Receptor 3 In Vitro

Kyu-Yeon Han,Michael Chang,Hong-Yu Ying,Hyun Lee,Yu-Hui Huang,Jin-Hong Chang,Dimitri T. Azar

DOI: https://doi.org/10.2174/0929866522666150907111953

2015-01-01

Protein and Peptide Letters

Abstract:We previously reported that neostatin, a proteolytic fragment of collagen XVIII that includes endostatin, inhibits basic fibroblast growth factor-induced corneal angiogenesis and lymphangiogenesis. In experiments to determine which fragments in neostatin are responsible for binding to VEGF receptors (VEGFRs), we previously showed that a 28-mer sequence at the C-terminal of endostatin, known as endostatin peptide 9, preferentially binds VEGFR3-Fc over VEGFR1-Fc and VEGFR2-Fc. In the present study, we show that a different endostatin fragment, endostatin peptide 4 (26 mers long), also selectively binds VEGFR3-Fc and not VEGFR1-Fc or VEGFR2-Fc. From surface plasmon resonance data, the K-D and Chi(2) (RU2) values for endostatin peptide 4 binding to VEGFR3-Fc are 5.72 x 10(-8) M and 0.354, respectively. In conclusion, endostatin peptides 4 and 9 may be responsible for endostatin binding to VEGFR3-Fc, and this improved understanding of endostatin peptide binding to VEGFR3-Fc may support the development of therapeutics targeting lymphangiogenic processes.